Galliprant 100 Mg 30s
Elanco Animal Health |
CA5812030AL

Galliprant 100 Mg 30s

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
Galliprant (grapiprant tablets) is the newest active ingredient approved to control the pain and inflammation associated with OA in dogs. Galliprant is part of a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs).

Active Ingredient
Grapiprant – 100mg

Galliprant 100mg is a once-daily, non-steroidal anti-inflammatory drug (NSAID) designed specifically to treat pain and inflammation associated with mild to moderate osteoarthritis in dogs. Its active ingredient, grapiprant, is a non-COX inhibiting prostaglandin receptor antagonist (PRA) that provides targeted pain relief with minimal impact on the kidneys, liver, or gastrointestinal system.
This 100mg strength is generally used for large dogs and is prescribed based on your pet’s weight and health profile.

Key Features
  • New generation NSAID for canine osteoarthritis
  • Targeted action reduces pain and inflammation at the source
  • Less risk to kidneys, liver, and gut compared to traditional NSAIDs
  • Once-daily oral tablet for easy compliance
  • Flavoured and chewable for improved palatability


Pack Size 30 flavoured tablets (100mg each)

Precautions
Not for use in dogs under 9 months of age or weighing less than 3.6kg
Not recommended for dogs with severe hepatic, renal, or cardiac conditions
Do not use with other NSAIDs or corticosteroids
Routine veterinary monitoring is recommended during long-term use
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription